Optimization of culture conditions to enhance mycophenoic acid biosyntheis by <i>Penicillium brevicompactum </i> BB263 isolated in Vietnam

Thanh Huyen Pham; Thi Mai Hoa Bach; Thi Thuy Duong Dang; Thi Minh Thanh Le; Thanh Ha Pham; Thanh Binh Chu; Phuong Nhue Nguyen

doi:10.15625/vjbt-21914

Author affiliations

Authors

Thanh Huyen Pham $^{1}$ Institute of Biotechnology, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam
Thi Mai Hoa Bach $^{1}$ Institute of Biotechnology, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam
Thi Thuy Duong Dang $^{1}$ Institute of Biotechnology, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam
Thi Minh Thanh Le $^{1}$ Institute of Biotechnology, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam
Thanh Ha Pham $^{1}$ Institute of Biotechnology, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam
Thanh Binh Chu $^{2}$ Institute of Military Preventive Medicine, 21 Trung Liet, Dong Da, Hanoi, Vietnam
Phuong Nhue Nguyen $^{1}$ Institute of Biotechnology, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam

DOI:

https://doi.org/10.15625/vjbt-21914

Keywords:

Box-Behnken design (BBD), conditions of medium, mycophenolic acid, MPA, Penicillium, Penicillium brevicompactum, submerged fermentation

Abstract

Mycophenolic acid (MPA) is an immunosuppressant utilized in organ transplantation to prevent rejection and in the treatment of autoimmune diseases such as Crohn's disease and systemic lupus erythematosus. Previous studies have reported that MPA is predominantly produced by fungal strains of the genus Penicillium, exhibiting immunosuppressive, antiviral, and antitumor activities, making it valuable in medical applications. In this study, we present the optimization of nutritional components in the fermentation medium for the fungal strain Penicillium brevicompactum BB263 to enhance MPA biosynthesis. Experiments were designed using the Box-Behnken methodology to assess the effects of three factors–sucrose, yeast extract, and methionine–on MPA production. The optimized medium for P. brevicompactum BB263, designated as YES-F1, comprises (per liter): sucrose 38.14 g, yeast extract 18.69 g, methionine 1.29 g, glycine 4 g, and trace elements 1 mL. Fermentation conditions include an initial pH of 6.5, a temperature of 25°C, an agitation speed of 200 rpm, and a harvest time of 114 hours post-inoculation. Following optimization, MPA production increased tenfold compared to the initial YES medium, reaching 969.79 µg/mL, corresponding to a yield exceeding 70% relative to the biomass of P. brevicompactum BB263. These findings provide a foundation for the industrial-scale production of MPA from Penicillium strains in Vietnam.

Downloads

References

Anand. S. & Srivastava, P. (2020). Optimization Strategies for Purification of Mycophenolic Acid Produced by Penicillium brevicompactum. Applied Biochemistry and Biotechnology, 191(2), 867–880. https://doi.org/10.1007/s12010-019-03204-w

Bentley, R. (2000). Mycophenolic acid: A one-hundred-year odyssey from antibiotic to mmunosuppressant. Chemical Reviews, 100(10), 3801–3825. https://doi.org/10.1021/cr990097b

Dong, C-H., Xie, X-Q., Wang, X-L., Zhan, Y. & Yao, Y-J. (2009). Application of Box-Behnken design in optimisation for polysaccharides extraction from cultured mycelium of Cordyceps sinensis. Food and Bioproducts Processing, 87(2), 139–144. https://doi.org/10.1016/j.fbp.2008.06.004

Dong, Y., Xu, R., Wang, L., Zhang, J., Bai, C., Sun et al. (2015). A combined feeding strategy for enhancing mycophenolic acid production by fed-batch fermentation in Penicillium brevicompactum. Process Biochemistry, 50, 336–340. https://doi.org/10.1007/s12010-022-03886-9

Elbarbry, F.A. & Shoker, A.S. (2007). Liquid chromatographic determination of mycophenolic acid and its metabolites in human kidney transplant plasma: Pharmacokinetic application. Journal of Chromatography B, 859(2), 276–281. https://doi.org/10.1016/j.jchromb.2007.09.036

Ferreira, P.C.L., Thiesen, F.V., Pereira, A.G., Zimmer, A.R., Fröehlich, P.E. (2020). A short overview on mycophenolic acid pharmacology and pharmacokinetics. Clinical Transplantation, 34: e13997. https://doi.org/10.1111/ctr.13997

Frisvad, J.C. (1981). Physiological criteria and mycotoxin production as aids in identiﬁcation of common asymmetric penicillia. Applied and Environmental Microbiology, 41, 568–579. https://doi.org/10.1128/aem.41.3.568-579.1981

Ismaiel, A.A., Ahmed, A.S. & El-Sayed, E-SR. (2014). Optimization of submerged fermentation conditions for immunosuppressant mycophenolic acid production by Penicillium roqueforti isolated from blue-molded cheeses: Enhanced production by ultraviolet and gamma irradiation. World Journal of Microbiology Biotechnology, 30(10), 2625–2638. https://doi.org/10.1007/s11274-014-1685-1

Patel, G., Patil, M.D., Soni, S., Khobragade, T.P., Chisti, Y. & Banerjee, U.C. (2016). Production of mycophenolic acid by Penicillium brevicompactum—A comparison of two methods of optimization. Biotechnology Reports (Amts), 11, 77–85. https://doi.org/10.1016/j.btre.2016.07.003

Ramos-Ponce, L.M., Contreras-Esquivel, J.C., Saenz, J.M., Lara-Cisneros, G. & Garza-Garcia, Y. (2012). Study on production of mycophenolic acid by Penicillium pinophilum using response surface metodology. 2012 IEEE 2nd Portuguese Meeting in Bioengineering (ENBENG). https://doi.org/10.1109/enbeng.2012.6331348

Regueira, T.B., Kildegaard, K.R., Hansen, B.G., Mortensen, U.H., Hertweck, C. & Nielsen, J. (2011). Molecular Basis for Mycophenolic Acid Biosynthesis in Penicillium brevicompactum. Applied and Environmental Microbiology, 77(9), 3035–3043. https://doi.org/10.1128/aem.03015-10

Zhang, W., Du, L., Qu, Z., Zhang, X., Li, F., Li, et al. (2019). Compartmentalized biosynthesis of mycophenolic acid. Proceedings of the National Academy of Sciences, 16(27), 13305-13310.

https://doi.org/10.1073/pnas.1821932116